Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative

Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative

<br><strong>Background: </strong>Psoriatic disease (PsD) is a complex systemic disorder with cutaneous and musculoskeletal (MSK) manifestations. Current evidence on pharmacological interventions –effective Across-The-Spectrum-Of-Clinical-Manifestations (ATSOCM) of early, systemic t...

Descripció completa

Dades bibliogràfiques
Autors principals:	De Marco, G, Berekméri, A, Coates, LC, Dubash, S, Emmel, J, Gladman, DD, Lubrano, E, McGonagle, DG, Mahmood, F, Marchesoni, A, Mason, L, Ogdie, A, Wittmann, M, Helliwell, PS, Marzo-Ortega, H
Format:	Journal article
Idioma:	English
Publicat:	Oxford University Press 2020

Ítems similars

Non tropical pharmacological treatment of early, untreated (Dmard-Naïve) psoriatic disease: A systematic review
per: De Marco, G, et al.
Publicat: (2019)

GRAPPA 2018 project report
per: Goel, N, et al.
Publicat: (2019)

Outcomes of the 2019 GRAPPA workshop on continuous composite indices for the assessment of psoriatic arthritis and membership: Recommended next steps
per: Tillett, W, et al.
Publicat: (2020)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
per: Soriano, ER, et al.
Publicat: (2023)

Initiating evaluation of composite outcome measures for psoriatic arthritis: 2022 updates from the GRAPPA-OMERACT Working Group
per: Leung, Y-Y, et al.
Publicat: (2023)

Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021
per: Coates, LC, et al.
Publicat: (2022)

GRAPPA-OMERACT initiative to standardise outcomes in psoriatic arthritis clinical trials and longitudinal observational studies
per: Tillett, W, et al.
Publicat: (2017)

New GRAPPA recommendations for the management of psoriasis and psoriatic arthritis: process, challenges and implementation
per: Coates, L, et al.
Publicat: (2016)

GRAPPA 2019 project report
per: Goel, N, et al.
Publicat: (2020)

Measurement properties of radiographic outcome measures in Psoriatic Arthritis: A systematic review from the GRAPPA-OMERACT initiative
per: Antony, A, et al.
Publicat: (2021)

Effect of secukinumab on the different GRAPPA-OMERACT core domains in psoriatic arthritis: a pooled analysis of 2049 patients
per: Orbai, A-M, et al.
Publicat: (2019)

The GRAPPA-OMERACT Working Group: 4 prioritized domains for completing the core outcome measurement set for psoriatic arthritis 2019 updates
per: Leung, YY, et al.
Publicat: (2020)

Inhibition of interleukin-17 in patients with oligoarticular psoriatic arthritis
per: Ogdie, A, et al.
Publicat: (2023)

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis
per: Coates, L, et al.
Publicat: (2017)

Management of dactylitis in patients with psoriatic arthritis: an updated literature review informing the 2021 GRAPPA treatment recommendations
per: Palominos, PE, et al.
Publicat: (2022)

Simulation-based design of pragmatic trials in psoriatic arthritis using propensity scores
per: Weinstein, SM, et al.
Publicat: (2021)

The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: similarities and differences
per: Coates, L, et al.
Publicat: (2022)

The GRAPPA-OMERACT Psoriatic Arthritis Working Group at the 2018 annual meeting: report and plan for completing the core outcome measurement set
per: Leung, Y, et al.
Publicat: (2019)

GRAPPA 2016 Project Report
per: Helliwell, P, et al.
Publicat: (2017)

Proceedings of the GRAPPA 2022 executive retreat
per: Ng, B, et al.
Publicat: (2023)

Screening/referral strategies for the early recognition of psoriatic arthritis (PsA) among patients with psoriasis: results of a GRAPPA survey
per: Song, K, et al.
Publicat: (2023)

Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
per: Helliwell, PS, et al.
Publicat: (2022)

Axial Involvement in Psoriatic Arthritis cohort (AXIS): the protocol of a joint project of the Assessment of SpondyloArthritis international Society (ASAS) and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)
per: Poddubnyy, D, et al.
Publicat: (2021)

GRAPPA 2017 Project Report
per: Callis Duffin, K, et al.
Publicat: (2018)

What should be the primary target of "treat to target" in psoriatic arthritis?
per: Coates, LC, et al.
Publicat: (2018)

Psoriatic arthritis: prospects for the future
per: Hackett, S, et al.
Publicat: (2022)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
per: Gladman, DD, et al.
Publicat: (2022)

Measuring outcomes in psoriatic arthritis
per: Ogdie, A, et al.
Publicat: (2020)

GRAPPA treatment recommendations: updates and methods
per: Kavanaugh, A, et al.
Publicat: (2020)

High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort
per: Richard J Wakefield, et al.
Publicat: (2024-05-01)

A presença da reumatologia brasileira no GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) The presence of the Brazilian rheumatology in the GRAPPA
per: Cláudia Goldenstein-Schainberg, et al.
Publicat: (2011-10-01)

The GOLMePsA study protocol: an investigator-initiated, double-blind, parallel-group, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
per: De Marco, G, et al.
Publicat: (2017)

Content and face validity and feasibility of 5 candidate instruments for psoriatic arthritis randomized controlled trials: The PsA OMERACT Core Set Workshop at the GRAPPA 2017 Annual Meeting
per: Holland, R, et al.
Publicat: (2018)

Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
per: Coates, L, et al.
Publicat: (2020)

Sex-specific differences in patients with psoriatic arthritis: a systematic review
per: Coates, LC, et al.
Publicat: (2022)

International treatment recommendations update: A report from the GRAPPA 2016 annual meeting
per: Coates, L, et al.
Publicat: (2017)

Relationships between psoriatic arthritis composite measures of disease activity with patient-reported outcomes in Phase 3 studies of tofacitinib
per: Coates, L, et al.
Publicat: (2021)

The benefits and challenges of setting up a longitudinal psoriatic arthritis database
per: Gladman, DD, et al.
Publicat: (2018)

Classification and outcome measures for psoriatic arthritis
per: Leung, Y, et al.
Publicat: (2018)

THE DIAGNOSIS OF PSORIATIC ARTHRITIS
per: P.S. Helliwell
Publicat: (2011-09-01)